MCWF (Amplimune) Offers an Alternative for Herd Health as FDA Further Restricts Antibiotics

Effective in June, 2023, all over-the-counter bovine antibiotics in the U.S. will be switched to prescription-only status. Amplimune immunotherapy offers an alternative to antibiotics that does not require a prescription.